Journal
CELL
Volume 153, Issue 5, Pages 1064-1079Publisher
CELL PRESS
DOI: 10.1016/j.cell.2013.04.055
Keywords
-
Categories
Funding
- Canadian Cancer Society Research Institute
- British Columbia Cancer Foundation
- National Institutes of Health [CA159859]
- Terry Fox Research Institute
- Pediatric Brain Tumor Foundation
- The Brain Tumour Charity [10/106] Funding Source: researchfish
Ask authors/readers for more resources
Metabolic adaptation is essential for cell survival during nutrient deprivation. We report that eukaryotic elongation factor 2 kinase (eEF2K), which is activated by AMP-kinase (AMPK), confers cell survival under acute nutrient depletion by blocking translation elongation. Tumor cells exploit this pathway to adapt to nutrient deprivation by reactivating the AMPK-eEF2K axis. Adaptation of transformed cells to nutrient withdrawal is severely compromised in cells lacking eEF2K. Moreover, eEF2K knockdown restored sensitivity to acute nutrient deprivation in highly resistant human tumor cell lines. In vivo, overexpression of eEF2K rendered murine tumors remarkably resistant to caloric restriction. Expression of eEF2K strongly correlated with overall survival in human medulloblastoma and glioblastoma multiforme. Finally, C. elegans strains deficient in efk-1, the eEF2K ortholog, were severely compromised in their response to nutrient depletion. Our data highlight a conserved role for eEF2K in protecting cells from nutrient deprivation and in conferring tumor cell adaptation to metabolic stress.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available